Russia tests COVID-19 vaccine as nasal spray for children – agencies | Inquirer News

Russia tests COVID-19 vaccine as nasal spray for children – agencies

/ 10:53 PM June 12, 2021

Alexander Gintsburg, director of the Gamaleya National Research Center for Epidemiology and Microbiology, attends an interview in Moscow

Alexander Gintsburg, director of the Gamaleya National Research Center for Epidemiology and Microbiology, shows bottles with Sputnik-V vaccine against the coronavirus disease (COVID-19) during an interview with Reuters in Moscow, Russia Sep. 24, 2020. (File photo from REUTERS)

MOSCOW — Russia has tested a nasal spray form of its COVID-19 vaccine that is suitable for children aged 8-12, and plans to launch the new product in September, the scientist who led the development of the Sputnik V vaccine said on Saturday.

Alexander Gintsburg, who heads the Gamaleya Institute that developed Sputnik V, said the spray for children used the same vaccine “only instead of a needle, a nozzle is put on”, the TASS news agency reported.

Article continues after this advertisement

The children’s shot is expected to be ready for distribution by Sept. 15, Gintsburg was quoted as saying during a meeting with President Vladimir Putin.

FEATURED STORIES

The research group tested the vaccine on children aged between eight and 12 and found no side effects among the test group, including no increase in body temperature, Gintsburg said in comments reported by the TASS news agency.

“We are inoculating our little (patients) nasally, we are just administering the same vaccine as a nasal spray,” Gintsburg said, without giving further details about the study such as how many children were involved.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.